Back Login for AI Analysis

    ELDN (STOCKS)

    Eledon Pharmaceuticals, Inc. Common Stock

    $3.540000
    -0.030000 (-0.84%)
    Prev close: $3.570000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    David-Alexandre C. Gros
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $266.30M
    Employees
    31
    P/E (TTM)
    -4.00
    P/B (TTM)
    6.05
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    4
    Strong Buy
    7
    Buy
    1
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Mar 2026 (Q1)
    		 $-0.33 $-0.19 -0.1438 -77.23%
    Dec 2025 (Q4)
    		 $-0.10 $-0.21 +0.1074 +51.78%
    Sep 2025 (Q3)
    		 $-0.21 $-0.26 +0.0450 +17.65%
    Jun 2025 (Q2)
    		 $-0.13 $-0.23 +0.1046 +44.59%
    Financial Statements
    TTM (Mar 2026)
    Operating Expenses $86.47M
    Research and Development $69.93M
    Other Operating Expenses $16.54M
    Income/Loss From Continuing Operations After Tax -$78.15M
    Income/Loss From Continuing Operations Before Tax -$78.11M
    Net Income/Loss -$78.15M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$78.15M
    Net Income/Loss Available To Common Stockholders, Basic -$74.12M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic -$4.03M
    Preferred Stock Dividends And Other Adjustments -$4.03M
    Basic Earnings Per Share -$0.77
    Diluted Earnings Per Share -$0.77
    Basic Average Shares 271,426,186
    Diluted Average Shares 271,426,186
    Assets $146.67M
    Current Assets $113.57M
    Cash $111.10M
    Other Current Assets $2.47M
    Noncurrent Assets $33.09M
    Liabilities $46.21M
    Current Liabilities $13.46M
    Accounts Payable $6.59M
    Other Current Liabilities $6.87M
    Noncurrent Liabilities $32.75M
    Equity $44.76M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $44.76M
    Liabilities And Equity $146.67M
    Net Cash Flow From Operating Activities -$68.89M
    Net Cash Flow From Operating Activities, Continuing -$68.89M
    Net Cash Flow From Investing Activities $12.86M
    Net Cash Flow From Investing Activities, Continuing $12.86M
    Net Cash Flow From Financing Activities $70.35M
    Net Cash Flow From Financing Activities, Continuing $70.35M
    Net Cash Flow $14.31M
    Net Cash Flow, Continuing $14.31M
    Comprehensive Income/Loss -$78.20M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$78.20M
    Other Comprehensive Income/Loss $35.12M